ProShares Ultra CRCL

ARCX

Leveraged/inverse product: higher risk; may not be available to trade. A quote does not mean the product is available to trade on your account.

Last traded price · USD

$14.01

+2.41%Market closed

Delayed 15 minutes · Source: ViewTrade · 5 Nov 2026, 06:30 IST · A quote does not mean the product is available to trade on your account.

Day's open: $13.33
Previous close: $13.68
Volume: 353,138
Day's high: $14.57
Day's low: $12.66

In brief

ProShares Ultra CRCL is an exchange-traded fund listed in the US.
Its shares closed at $14.07 on 4 Nov 2026, down 84.9% over the past year.
From India you can buy CRCA in US dollars under the RBI's Liberalised Remittance Scheme, including a fraction of one share. See what it costs

Questions investors ask

Can I buy ProShares Ultra CRCL (CRCA) shares from India?

Yes. Indian residents can invest in the US stock market under the Reserve Bank of India's Liberalised Remittance Scheme (LRS), which lets a resident individual remit up to USD 250,000 per financial year, across all permitted purposes combined. US-listed stocks and ETFs are a permitted investment under the LRS. You are solely responsible for ensuring your remittances comply with the LRS annual limit, the applicable Tax Collected at Source (TCS) rules, and all reporting requirements, including Schedule FA in your income-tax return.

Do I need the price of a whole CRCA share to invest?

Yes. You can buy fractional shares, which lets you invest a fixed rupee/dollar amount even in high-priced stocks. For example, if one share trades at USD 1,000 and you invest USD 100, you receive 0.1 of a share.

How much can I invest in US stocks in a year?

Under the LRS, an Indian resident can remit up to USD 250,000 per financial year (April to March) across all permitted purposes combined, from their own funds. This is a per-individual limit set by the RBI.

Can I trade CRCA options or futures?

No. Under RBI / FEMA rules, the LRS does not permit margin trading or speculative instruments such as futures, options, or other derivatives. Your US account is a cash account, not a derivatives and margin account.

Insights

Quotes run fifteen minutes behind.

Behind SPY over 1 year
1 month: −22.5% (SPY −1.6%). 3 months: +16.1% (SPY −0.4%). 1 year: −84.9% (SPY +13.6%). Price change to the 4 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: CRCA, SPY · as of 4 Nov 2026
39.7% above its 52-week low
Closed at $14.07 on 4 Nov 2026: 85.5% below the 52-week high of $96.80 (6 Nov 2025) and 39.7% above the low of $10.07 (3 Aug 2026).
Daily price bars, split-adjusted · as of 4 Nov 2026
Below its 50- and 200-day averages
The 4 Nov 2026 close of $14.07 was 28.4% below its 50-day average ($19.64) and 52.8% below its 200-day average ($29.81).
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026
1.2M shares sold short
1.2M shares were sold short at the 15 Oct 2026 settlement; covering them would take 2.6 days of average volume. Short interest is reported twice a month, on a lag.
Exchange short-interest filing · as of 15 Oct 2026

Returns

Price return, split-adjusted

At the 4 Nov 2026 close

1 month−22.5%

6 months−76.4%

1 year−84.9%

5 years—

Newswire

About

Notable moves

May 4, 2026
+40.13%
March 24, 2026
−40.51%
February 25, 2026
+70.23%

ProShares Ultra CRCL

ARCX

Leveraged/inverse product: higher risk; may not be available to trade. A quote does not mean the product is available to trade on your account.

Last traded price · USD

$14.01

+2.41%Market closed

Delayed 15 minutes · Source: ViewTrade · 5 Nov 2026, 06:30 IST · A quote does not mean the product is available to trade on your account.

Day's open: $13.33
Previous close: $13.68
Volume: 353,138
Day's high: $14.57
Day's low: $12.66

In brief

ProShares Ultra CRCL is an exchange-traded fund listed in the US.
Its shares closed at $14.07 on 4 Nov 2026, down 84.9% over the past year.
From India you can buy CRCA in US dollars under the RBI's Liberalised Remittance Scheme, including a fraction of one share. See what it costs

Questions investors ask

Can I buy ProShares Ultra CRCL (CRCA) shares from India?

Do I need the price of a whole CRCA share to invest?

How much can I invest in US stocks in a year?

Can I trade CRCA options or futures?

Insights

Quotes run fifteen minutes behind.

Behind SPY over 1 year
1 month: −22.5% (SPY −1.6%). 3 months: +16.1% (SPY −0.4%). 1 year: −84.9% (SPY +13.6%). Price change to the 4 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: CRCA, SPY · as of 4 Nov 2026
39.7% above its 52-week low
Closed at $14.07 on 4 Nov 2026: 85.5% below the 52-week high of $96.80 (6 Nov 2025) and 39.7% above the low of $10.07 (3 Aug 2026).
Daily price bars, split-adjusted · as of 4 Nov 2026
Below its 50- and 200-day averages
The 4 Nov 2026 close of $14.07 was 28.4% below its 50-day average ($19.64) and 52.8% below its 200-day average ($29.81).
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026
1.2M shares sold short
1.2M shares were sold short at the 15 Oct 2026 settlement; covering them would take 2.6 days of average volume. Short interest is reported twice a month, on a lag.
Exchange short-interest filing · as of 15 Oct 2026

Returns

Price return, split-adjusted

At the 4 Nov 2026 close

1 month−22.5%

6 months−76.4%

1 year−84.9%

5 years—

Newswire

About

Notable moves

May 4, 2026
+40.13%
March 24, 2026
−40.51%
February 25, 2026
+70.23%

ProShares Ultra CRCL

ProShares Ultra CRCL in brief

Behind SPY over 1 year

39.7% above its 52-week low

Below its 50- and 200-day averages

1.2M shares sold short

ProShares Ultra CRCL

ProShares Ultra CRCL in brief

Behind SPY over 1 year

39.7% above its 52-week low

Below its 50- and 200-day averages

1.2M shares sold short